The shelf life of smegglutide is typically 36 months, or approximately 3 years. This refers to the effective period of the drug if unopened and properly stored. Once this period is exceeded, the drug's efficacy may gradually diminish, thus affecting treatment effectiveness.
Smegglutide injection can be used for glycemic control in adult patients with type 2 diabetes who are not achieving target blood glucose levels with metformin or sulfonylureas, in addition to diet and exercise. Before first use, smegglutide injection should be stored in a refrigerator at a suitable temperature of 2-8°C. After opening, i.e., after the first use, the drug can usually be stored for about 6 weeks. This is because the drug's stability may be affected after opening, so it needs to be used within a short period to ensure efficacy.
It is important to note that the shelf life and storage conditions of a drug are crucial for maintaining its effectiveness and safety. Improper storage, such as excessively high temperatures or exposure to sunlight, may cause the drug to deteriorate, thus shortening its shelf life. Therefore, when using Smegglutide injection, it is essential to follow the doctor's instructions and carefully monitor the expiration date and storage conditions to ensure the safety and effectiveness of the medication.
It is also important to note that Smegglutide injection is primarily used to treat type 2 diabetes. During use, it is crucial to monitor the patient's blood glucose levels and adjust the dosage as needed. Furthermore, as the medication may cause adverse reactions such as hypoglycemia, nausea, diarrhea, and vomiting, it is necessary to closely observe the patient's reactions and address them promptly.